SYN-NIC-7 TRANSDERMAL ONEIRIC INDUCTION SYSTEM

nicotine transdermal patch, program use only. Synesthesia Health Division, a subsidiary of the Synesthesia Corporation.

document SYN-HLTH-INS-007 rev. K. read fully before lights out.

BOXED WARNINGSYN-NIC-7 is worn during sleep. This is contrary to the general instruction printed on commercial nicotine patches. That instruction exists because overnight wear produces abnormally vivid dreams. Vivid dreams are the indication. Do not enroll if you are unwilling to remember what you see. Do not operate the dream machine while awake. Do not wear more than one system at a time, regardless of what the dream told you.

SYN-NIC-7 is indicated for the induction of high-recall, high- vividness REM sleep in Phase IV program subjects, in preparation for artifact recovery sessions. It is not indicated for smoking cessation. Subjects who begin smoking in order to qualify for the patch have misunderstood the program and will be reassigned.

Apply one system to clean, dry skin on the upper arm at lights out. Remove upon final waking. Site rotation per the table below. Titration is managed by your Program Coordinator and is not self-directed.

Program weekSystemWear windowReporting
13 to 14SYN-NIC-7 / LOWfinal REM cycle onlywritten report, morning
15 to 18SYN-NIC-7 / STDfull nightwritten report, morning
19 and onSYN-NIC-7 / STDfull night, monitoredverbal debrief, on site

The LOW system is a STD system cut in half. The Health Division is aware the manufacturer says not to cut the patch. See boxed warning regarding the manufacturer's general posture toward our work.

  • cardiovascular conditions, per standard nicotine labeling
  • pregnancy or nursing
  • concurrent restricted-tier cholinergics (see the index)
  • a history of preferring the dream to the morning. screening question 44 addresses this. answer it honestly.

Reported by more than five percent of Phase IV subjects:

  • application site irritation
  • false awakenings, sometimes serial
  • waking with completed dream reports already written
  • recognition of dream locations in subsequent corporate media releases
  • homesickness for places that do not exist

Report adverse events to corporate@synesthesia.systems with subject line ADVERSE EVENT and your subject number. Do not describe the event in the subject line. We have asked before.

SYN-NIC-7 is one entry in a 43-substance research index published in the corporate diary. Interactions within the index are managed at the protocol level. Consult the program page for the current phase structure, or the Oneironaut's Index for the full annotated catalog.

Cartons of 14 systems, dispensed on site, two-week intervals. Systems are serialized and reconciled against your dream reports. Unreturned backing film is noted in your file.